Cutting meals or straying from the diet plan can lead to fluctuations in blood sugar levels, potentially resulting in hypoglycemia and interference with the effects of the weight loss drug
When a user records their nutrition, logs a weight check-in, or tracks a weekly injection, their digital pet grows, gains energy, or unlocks items
A 2021 analysis published in Cardiovascular Diabetology found that semaglutide produced significant reductions in triglycerides and total cholesterol alongside its weight loss effects, with improvements correlating strongly with the degree of weight lost (Husain et al., Cardiovascular Diabetology, 2021, Tirzepatide and Cholesterol: Does the Dual Mechanism Help More For patients with significant lipid abnormalities, tirzepatide may offer an advantage over semaglutide
2,32,33 POTENTIAL FUTURE THERAPIES Given the elevated GLP-1 levels and robust insulin response to glucose observed in PGBH, blocking GLP-1 may provide clinical benefit